Eagle Pharmaceuticals: Q4 Earnings Snapshot

WOODCLIFF LAKE, N.J. (AP) — WOODCLIFF LAKE, N.J. (AP) — Eagle Pharmaceuticals Inc. (EGRX) on Monday reported fourth-quarter net income of $8.2 million, after reporting a loss in the same period a year earlier.

The Woodcliff Lake, New Jersey-based company said it had net income of 62 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were $1.10 per share.

The specialty pharmaceutical company posted revenue of $60.7 million in the period.

For the year, the company reported net income of $35.6 million, or $2.73 per share, swinging to a profit in the period. Revenue was reported as $316.6 million.

Eagle Pharmaceuticals expects full-year earnings in the range of $4.20 to $4.53 per share.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up